Physician profile
Rebeccah L Brown
NPI 1295787596
$66,819.13
in general payments reported to CMS, 2019-2025
6 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2021: $1,505 · 2022: $2,472 · 2023: $21K · 2024: $15K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $6,365 · Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,505.00 |
| Travel and Lodging | $6,365.34 |
| Food and Beverage | $2,059.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $62,479.45 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Zimmer Biomet Holdings, INC. | $3,993.36 | 2019-2024 | Medline |
| Kls-Martin L.P. | $176.70 | 2024-2025 | |
| Vericel Corporation | $81.48 | 2024 | Nexobrid |
| Next Science LLC | $44.15 | 2024 | Surgx, Blastx, Xperience |
| Glaxosmithkline, LLC. | $43.99 | 2019-2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebeccah Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.